PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

INTRODUCTION: Targeting the CD20 antigen has been a successful therapeutic intervention in the treatment of rheumatoid arthritis (RA). However, in some patients with an inadequate response to anti-CD20 therapy, a persistence of CD20(-) plasmablasts is noted. The strong expression of CD319 on CD20(-)...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Jacky, Vierboom, Michel PM, Kwon, Hakju, Chao, Debra, Ye, Shiming, Li, Jianmin, Lin, Karen, Tang, Irene, Belmar, Nicole A, Hartman, Taymar, Breedveld, Elia, Vexler, Vladimir, ‘t Hart, Bert A, Law, Debbie A, Starling, Gary C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978732/
https://www.ncbi.nlm.nih.gov/pubmed/24299175
http://dx.doi.org/10.1186/ar4400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978732/
https://www.ncbi.nlm.nih.gov/pubmed/24299175
http://dx.doi.org/10.1186/ar4400

Ejemplares similares